Therefore, we thoroughly conducted a comprehensive systematic review and literature analysis of all prospective clinical studies on HER2-targeted ADCs to investigate the incidence of CEs at all grades and ≥3/serious grades, and identify the factors influencing these events. This evidence concerns the gene ERBB2 and cat-eye syndrome.